Cargando…

Can adjuvant radiotherapy be omitted for oral cavity cancer patients who received neoadjuvant therapy and surgery? A retrospective cohort study

Surgery and postoperative adjuvant therapy comprise the standard treatment for locally advanced resectable oral squamous cell carcinoma (LAROSCC), while preoperative neoadjuvant therapy is being explored without sufficient confirmation of improved survival. De-escalation regimens after neoadjuvant t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ju, Wutong, Zhang, Yiyi, Liu, Ying, Sun, Jingjing, Li, Jiang, Dong, Minjun, Sun, Qi, Shi, Wentao, Zhao, Tongchao, Zhou, Zhihang, Huang, Yingying, Zhou, Xinyu, Zhu, Dongwang, Dou, Shengjin, Zhang, Zhiyuan, He, Yue, Zhang, Chenping, Xia, Ronghui, Zhu, Guopei, Zhong, Laiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389426/ https://www.ncbi.nlm.nih.gov/pubmed/36999830 http://dx.doi.org/10.1097/JS9.0000000000000353

Ejemplares similares

Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial)
por: Huang, Yingying, et al.
Publicado: (2023)

Decreased Annexin A1 expression enhances sensitivity to docetaxel, cisplatin and 5‐fluorouracil combination induction chemotherapy in oral squamous cell carcinoma
por: Sun, Wenwen, et al.
Publicado: (2021)

Diagnosis and management of hypoglossal nerve-derived schwannoma in the floor of mouth: a case series
por: Zhong, Jiayong, et al.
Publicado: (2022)

Clinical retrospective analysis with a predictive model for diffused-tenosynovial giant cell tumors of the temporomandibular joint
por: Liu, Ying, et al.
Publicado: (2023)

A feasibility and safety study of concurrent chemotherapy based on genetic testing in patients with high-risk salivary gland tumors: Preliminary results
por: Li, Rongrong, et al.
Publicado: (2018)

Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study
por: Dou, Shengjin, et al.
Publicado: (2020)

Apatinib in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a single-arm, phase II prospective study
por: Zhu, Guopei, et al.
Publicado: (2021)

The feasibility of omitting irradiation to the contralateral lower neck in stage N1 nasopharyngeal carcinoma patients
por: Hu, Weixu, et al.
Publicado: (2013)

MFAP5 and TNNC1: Potential markers for predicting occult cervical lymphatic metastasis and prognosis in early stage tongue cancer
por: Yang, Xi, et al.
Publicado: (2016)

Efficacy and feasibility of Apatinib and S-1 as a novel oral induction therapy in locally advanced head and neck squamous cell carcinoma: an exploratory phase 2 open-label, single-arm trial
por: Jiang, Wen, et al.
Publicado: (2023)

Tailored multimodality therapy guided by a two-step decision making process for head-and-neck cancer of unknown primary
por: Dou, Shengjin, et al.
Publicado: (2016)

Omitted Acknowledgment
Publicado: (2020)

Reference Omitted
Publicado: (2023)

Luminal A Breast Cancer: How Feasible is Omitting Axillary Dissection Without Neoadjuvant Therapy
por: Yüksel, Cemil, et al.
Publicado: (2022)

GoldCLIP: Gel-omitted Ligation-dependent CLIP
por: Gu, Jiaqi, et al.
Publicado: (2018)

Longitudinal Body Composition Changes and the Importance of Fat-Free Mass Index in Locally Advanced Nasopharyngeal Carcinoma Patients Undergoing Concurrent Chemoradiotherapy
por: Ding, Huiping, et al.
Publicado: (2018)

Should Intercepting Traps Be Omitted?
Publicado: (1912)

EGFR Mutation and 11q13 Amplification Are Potential Predictive Biomarkers for Immunotherapy in Head and Neck Squamous Cell Carcinoma
por: Dou, Shengjin, et al.
Publicado: (2022)

Combined all‐trans retinoic acid with low‐dose apatinib in treatment of recurrent/metastatic head and neck adenoid cystic carcinoma: A single‐center, secondary analysis of a phase II study
por: Ye, Lulu, et al.
Publicado: (2023)

Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
por: Park, Jaehyeon, et al.
Publicado: (2021)

China’s little-known efforts to protect its marine ecosystems safeguard some habitats but omit others
por: Bohorquez, John J., et al.
Publicado: (2021)

Electrophysiological response to omitted stimulus in sentence processing
por: Nakano, Hiroko, et al.
Publicado: (2014)

Omitted Information on Data and Safety Monitoring Board
Publicado: (2022)

Omit needless words: Sentence length perception
por: Matthews, Nestor, et al.
Publicado: (2023)

Omitting histopathology in wrist ganglions. A risky proposition
por: Zubairi, Akbar J., et al.
Publicado: (2016)

Welfare Consequences of Omitting Beak Trimming in Barn Layers
por: Riber, Anja B., et al.
Publicado: (2017)

Note Omitted in Dr Stratton's Paper, Page 270
Publicado: (1849)

Omitted Description of and Citation to Previously Published Related Study
Publicado: (2020)

Oral health omitted from Early Years Review
Publicado: (2021)

Oral health omitted from Early Years Review
Publicado: (2021)

A Chapter Omitted in Most Treatises on General Pathology
Publicado: (1856)

Omitted Author, Funding Information, and Study Group Members
Publicado: (2022)

Omitting the systematic prostate biopsy: ready for prime time?
por: Leong, Joon Yau, et al.
Publicado: (2023)

The Immune Landscape of Chinese Head and Neck Adenoid Cystic Carcinoma and Clinical Implication
por: Dou, Shengjin, et al.
Publicado: (2021)

OMIT: Dynamic, Semi-Automated Ontology Development for the microRNA Domain
por: Huang, Jingshan, et al.
Publicado: (2014)

The omitted symptoms challenge the diagnosis of right atrial myxoma: a case report
por: Ma, Shulun, et al.
Publicado: (2020)

CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Feng, Zhien, et al.
Publicado: (2011)

Adjuvant therapy may be omitted for oral cavity cancer with only one positive lymph node
por: Chen, Wan‐Yu, et al.
Publicado: (2021)

Omitted variable tests and dynamic specification: an application to demand homogeneity
por: Fandel, G, et al.
Publicado: (1974)

Barriers to Achieving Glycemic Targets: Who Omits Insulin and Why?
por: Weinger, Katie, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ims8jv525oq2t57ukqonnvk9h9